PubMed Health⌕ Search

Biomedical subjects

J B Scrimgeour

Publications and source records attributed to J B Scrimgeour.

At least 19 recordsLinked to original sources
PubMed1999

Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.

PURPOSE: Tamoxifen is the most commonly prescribed adjuvant therapy for women with breast cancer. It has agonist activity on the endometrium and is associated with an increased risk of endometrial cancer. The aim of this study was to evaluate whether screening with transvaginal ultrasound (TV USS) with or without hysteroscopy is worthwhile. PATIENTS AND METHODS: A total of 487 women with breast cancer, 357 treated with tamoxifen and 130 controls, were screened with TV USS, and endometrial thickness was measured. Women with thickened endometrium underwent outpatient hysteroscopy. RESULTS: Length of time on tamoxifen ranged from 5 to 191 months (mean, 66 months), and endometrial thickness ranged from 1 to 38 mm (mean, 7.3 mm). Women treated with tamoxifen had significantly thicker endometrium than did controls (P <.0001). There was a statistically significant (P <.0001) positive correlation between length of time on tamoxifen and endometrial thickness. One hundred forty-five women had endometrium greater than 5 mm on USS, and 134 underwent successful outpatient hysteroscopy, 61 of whom had atrophic endometrium, resulting in a 46% false-positive scan rate. The remaining women all had benign features to explain the USS findings. CONCLUSION: TV USS detects a high incidence (41%) of apparent endometrial thickening in women treated with tamoxifen, although 46% had atrophic endometrium on further assessment, and none of the remaining asymptomatic women had significant lesions. Length of time on tamoxifen relates to endometrial thickening as measured by TV USS. TV USS is a poor screening tool because of the high false-positive rate. The low frequency of significant findings suggests that endometrial screening in asymptomatic women is not worthwhile.

Adult↗
PubMed1992

Prevalence of HIV among childbearing women and women having termination of pregnancy: multidisciplinary steering group study.

OBJECTIVE: To determine the prevalence of HIV among pregnant women, in particular those whose behaviour or that of their partners put them at "low risk" of infection. DESIGN: Voluntary named or anonymous HIV testing of pregnant women during 21 months (November 1988 to July 1990). SUBJECTS AND SETTING: All women who planned to continue their pregnancy and attended clinics serving the antenatal populations of Edinburgh and Dundee. All women admitted for termination of pregnancy to gynaecology wards serving the pregnant populations of Dundee and outlying rural areas. MAIN OUTCOME MEASURES: Period prevalence of HIV antibody positivity. RESULTS: 91% of antenatal clinic attenders and 97% of women having termination of pregnancy agreed to HIV testing on a named or anonymous basis. HIV period prevalences for antenatal clinic attenders and women having termination of pregnancy tested in Dundee were 0.13% and 0.85% respectively, and for antenatal clinic attenders tested in Edinburgh 0.26%. For those at "low risk" rates for antenatal clinic attenders and women having termination of pregnancy in Dundee were 0.11% and 0.13%, and for antenatal clinic attenders in Edinburgh 0.02%. In Dundee HIV prevalence among women having a termination of pregnancy (0.85%) was significantly greater than that among antenatal clinic attenders (0.13%). CONCLUSIONS: HIV infection is undoubtedly occurring among women at "low risk," and it is clear that a policy of selective testing of those at only "high risk" is inadequate for pregnant women living in areas of high prevalence such as Edinburgh and Dundee. Moreover, when studying pregnant populations in such areas there is the need to include those having a termination of pregnancy.

Abortion, Induced↗
PubMed1982

Maternal plasma alpha-fetoprotein and low birthweight: a prospective study throughout pregnancy.

Maternal plasma alpha-fetoprotein (AFP) was measured serially between 15 weeks gestation and term in 520 patients. Thirty-seven of these women were delivered of normal singleton infants with birthweights less than 2.5 kg. The median plasma AFP values in this group of women were highest between 15 and 20 weeks gestation and then declined steadily towards term. It is concluded that the use of maternal plasma or serum AFP in the early detection of low birthweight babies is optimal in the period most suitable for screening for fetal neural tube defects.

Female↗
PubMed1981

Very low maternal plasma alpha-fetoprotein concentration. An indication for follow-up.

In the course of a screening programme for the detection of fetal neural tube abnormalities by measurement of maternal plasma alpha-fetoprotein (AFP), 57 patients were identified who had plasma AFP levels of less than 7 units/ml at 15-20 weeks gestation. follow-up at the time of screening included requests to confirm that the patient was pregnant and also to repeat the AFP test. Tow patients were lost to follow-up and of the remaining 55, 17 patients (31 per cent) were subsequently shown not to have a live fetus and 31 patients (56 per cent) had incorrect estimates of gestation. No particular reason for the very low plasma AFP could be identified in the other seven patients.

Adolescent↗
PubMed1980

Development of the gonad in normal and anencephalic human fetuses.

The development of the germinal and somatic cells in the gonads of normal and anencephalic fetuses was investigated. Interstitial cells were reduced in number in both sexes and in males the population of gonocytes in profiles of seminiferous tubules was reduced when Leydig cells were seeminaly absent. Ovarian differentiation up to about 34 weeks after conception was apparently normal, although precise counts of the numbers of germ cells were not carried out. Nevertheless, oogonia increased in number by mitotic divisions, oocytes progressed through meiotic prophase to the diplotene stage, and primordial follicles formed normally. By contrast, 'growing' and small antral follicles, which are a constant feature of control ovaries, were not observed in the anencephalic specimens.

Anencephaly↗
PubMed1979

Significance of elevated mid-trimester maternal plasma-alpha-fetoprotein values.

In a prospective trial of 15,481 pregnancies, 667 women (4.3%) had two sequential mid-trimester plasma-alpha-fetoprotein (A.F.P.) values above 2 times the median. The outcome of these pregnancies was open neural-tube defect (12.4%), birthweight less than 2.5 kg (10.3%), twins (9.8%), fetal wastage (9.5%), perinatal death (2.6%), other (1.3%), and "normal" singleton (54.1%). At higher A.F.P. cutoffs the proportion of "normal" singleton pregnancies declined rapidly, being 19% at 3 times the median and 9% at 4 times the median. If it is assumed that ultrasonography and amniotic-fluid A.F.P. assay can detect twins and most cases of neural-tube defect, the outcome of the residual pregnancies is still strongly influenced by plasma-A.F.P. level. Thus at a cut-off of 4 times the median two-thirds of the pregnancies in this residual group will end in spontaneous abortion, stillbirth, or neonatal death. It is suggested that counselling of women taking part in A.F.P. screening programmes should be strongly influenced by maternal plasma-A.F.P. levels, even if ultrasonographic findings and amniotic-fluid levels are normal.

Birth Weight↗
PubMed1979

The relation between maternal plasma alpha-fetoprotein and birth weight in twin pregnancies.

In the course of routine screening for neural tube defects, maternal plasma alpha-fetoprotein (AFP) was measured between 15 and 23 weeks of gestation in 64 twin pregnancies. Women with AFP levels more than twice the median for singleton pregnancies gave birth to infants with significantly decreased birth weights. Women with AFP less than the median also tended to produce twins with decreased birth weights. The distribution of gestations at delivery suggested that in twin pregnancies low AFP values gave an early warning of growth retardation while high values signal possible premature delivery.

Birth Weight↗
PubMed1978

Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.

Maternal plasma alpha-fetoprotein (AFP) screening for fetal neural tube defects (NTD) was used as a part of routine antenatal care in three hospitals over a 26 month period. Blood samples were obtained for plasma AFP measurement at 15 to 20 weeks gestation from 6377 women, representing 79 per cent of antenatal bookings. The outcome of pregnancy was ascertained in 96 per cent of patients: 13 cases of anencephaly and 7 of open spina bifida were detected by plasma screening and a further 3 cases of open NTD through the mother's previous medical history and amniotic fluid determination. Four fetuses with open NTDs and four with closed NTDS were not detected by plasma AFP measurement and the detection efficiency for open NTDs was thus 83 per cent. Integration of screening into the existing pattern of antenatal care required only minor alterations in clinic schedules. Some extra time was needed for explanation of the objectives of the study, for ultrasound examination and for amniocentesis. Eight patients declined the offer of a plasma test, while only one refused an amniocentesis.

Amniotic Fluid↗
PubMed1977

Maternal serum-alpha-fetoprotein measurements as an early indicator of low birth-weight.

In a prospective trial of 4224 pregnancies, 103 women had serum-alpha-fetoprotein (A.F.P.) above 2-3 times the median value for their stage of gestation. 10-7% of these delivered infants with birth-weights less than 2-5 kg. This was significantly greater than the rate of 4-2% for low-birth-weight infants in the general population. At higher multiples of the median serum-A.F.P. value the proportion of pregnancies leading to low-birth-weight infants was even greater. It is suggested that early identification of pregnancies with high risk of premature delivery may be an important corollary of maternal serum A.F.P. screening.

Birth Weight↗